HomeCompareRUBY vs HDV

RUBY vs HDV: Dividend Comparison 2026

RUBY yields 3508.77% · HDV yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RUBY wins by $2034141393542.06M in total portfolio value
10 years
RUBY
RUBY
● Live price
3508.77%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2034141393542.08M
Annual income
$1,926,153,862,282,748,700.00
Full RUBY calculator →
HDV
iShares Core High Dividend ETF
● Live price
2.92%
Share price
$135.39
Annual div
$3.96
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$352.73
Full HDV calculator →

Portfolio growth — RUBY vs HDV

📍 RUBY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRUBYHDV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RUBY + HDV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RUBY pays
HDV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBY
Annual income on $10K today (after 15% tax)
$298,245.61/yr
After 10yr DRIP, annual income (after tax)
$1,637,230,782,940,336,400.00/yr
HDV
Annual income on $10K today (after 15% tax)
$248.52/yr
After 10yr DRIP, annual income (after tax)
$299.82/yr
At 15% tax rate, RUBY beats the other by $1,637,230,782,940,336,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBY + HDV for your $10,000?

RUBY: 50%HDV: 50%
100% HDV50/50100% RUBY
Portfolio after 10yr
$1017070696771.05M
Annual income
$963,076,931,141,374,500.00/yr
Blended yield
94.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RUBY right now

RUBY
Analyst Ratings
5
Buy
3
Hold
1
Sell
Consensus: Buy
Altman Z
-81.9
Piotroski
2/9
HDV
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBY buys
0
HDV buys
0
No recent congressional trades found for RUBY or HDV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRUBYHDV
Forward yield3508.77%2.92%
Annual dividend / share$2.00$3.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2034141393542.08M$24.3K
Annual income after 10y$1,926,153,862,282,748,700.00$352.73
Total dividends collected$2026733119198.63M$3.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RUBY vs HDV ($10,000, DRIP)

YearRUBY PortfolioRUBY Income/yrHDV PortfolioHDV Income/yrGap
1← crossover$361,577$350,877.19$11,002$292.38+$350.6KRUBY
2$12,243,821$11,856,933.69$12,084$300.36+$12.23MRUBY
3$388,336,948$375,236,059.53$13,250$308.02+$388.32MRUBY
4$11,538,279,357$11,122,758,822.00$14,506$315.35+$11538.26MRUBY
5$321,205,540,543$308,859,581,631.20$15,858$322.35+$321205.52MRUBY
6$8,379,307,864,544$8,035,617,936,162.96$17,313$329.04+$8379307.85MRUBY
7$204,877,671,222,196$195,911,811,807,134.25$18,878$335.42+$204877671.20MRUBY
8$4,695,974,086,156,479$4,476,754,977,948,728.50$20,560$341.49+$4695974086.14MRUBY
9$100,922,926,410,592,910$95,898,234,138,405,470.00$22,367$347.25+$100922926410.57MRUBY
10$2,034,141,393,542,082,800$1,926,153,862,282,748,700.00$24,307$352.73+$2034141393542.06MRUBY

RUBY vs HDV: Complete Analysis 2026

RUBYStock

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Full RUBY Calculator →

HDVETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →
📬

Get this RUBY vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBY vs SCHDRUBY vs JEPIRUBY vs ORUBY vs KORUBY vs MAINRUBY vs VYMRUBY vs DVYRUBY vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.